The AI-Mind 9th General Assembly Gathers Experts in Madrid
On October 28-29, 2023, AI-Mind partners from The Complutense University of Madrid (UCM) hosted the 9th General Assembly in Madrid, Spain, welcoming over 50 in-person and around 20 online participants. This key event offered an invaluable platform to review project progress, tackle challenges, and outline the next steps toward bringing AI-based dementia risk prediction tools into clinical practice.
Work package leaders presented updates on recent achievements including preliminary analysis of data collected within the study. The assembly also served as an excellent platform for a workshop on the Collective Evaluation of Experience, Explainability, and Practices in AI-Mind, facilitating collaborative discussions on refining AI-Mind tools to meet real-world clinical needs.
Discussions of the 9th GA focused on:
- Collaboration with European and global projects that is vital for the sustainability and future adoption of our comprehensive project data.
- Stakeholder involvement and preparing European health systems and legislation for the integration of AI-based dementia tools as well as dementia risk management.
- Clinical relevance and positioning AI-Mind in dementia and mild cognitive impairment (MCI) diagnostic pathways.
- Diversity within AI-Mind harnesses the project’s heterogeneity to strengthen outcomes and broaden impact.
The assembly also featured insightful guest lectures from leading experts. Paolo Maria Rossini delivered an insightful talk on “Why and where neurophysiological approaches are more informative than ‘traditional’ neuroimaging,” emphasizing the diagnostic potential of advanced neurophysiological methods.
Giovanni Frisoni from Hôpitaux Universitaires de Genève discussed the evolving landscape of Alzheimer’s treatment and prevention, including the current practices of the memory clinics and the need to focus on risk assessment, communication, and reduction. Frisoni noted, “Today we do not have a patient journey in memory clinics. What we can do at the current point is risk assessment, risk communication, risk reduction, and cognitive enhancement.” This underscores the need for a comprehensive patient journey in memory care, a goal that the European Task Force for Brain Health aims to address and to which AI-Mind aims to contribute.